Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Myer

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cell|February 11, 2009
Bidirectional transport of amino acids regulates mTOR and autophagyPaul Nicklin, Philip Bergman, Bailin Zhang, et al.
EMBO Reports|October 30, 2013
Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondinYang Xie, Raffaella Zamponi, Olga Charlat, et al.
Chemistry & Biology|September 15, 2015
Metabolic Enzyme Sulfotransferase 1A1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth SuppressionDeborah M Rothman, Xiaolin Gao, Elizabeth George, et al.
Plos One|September 18, 2015
Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor LineagesAnupama Reddy, Joseph D Growney, Nick S Wilson, et al.
Cancer Discovery|August 10, 2012
Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growthFred Harbinski, Vanessa J Craig, Sneha Sanghavi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersGregory R Hoffman, Rami Rahal, Frank Buxton, et al.
Plos One|July 21, 2012
R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5Heinz Ruffner, Joëlle Sprunger, Olga Charlat, et al.
Nature Communications|June 24, 2021
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesLiyang Zhang, John A Zuris, Ramya Viswanathan, et al.
Nature Medicine|February 10, 2025
A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levelsFrederic Tremblay, Qiang Xiong, Shrijal S Shah, et al.
Nature Medicine|January 22, 2019
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10Morgan L Maeder, Michael Stefanidakis, Christopher J Wilson, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cell|February 11, 2009
Bidirectional transport of amino acids regulates mTOR and autophagyPaul Nicklin, Philip Bergman, Bailin Zhang, et al.
EMBO Reports|October 30, 2013
Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondinYang Xie, Raffaella Zamponi, Olga Charlat, et al.
Chemistry & Biology|September 15, 2015
Metabolic Enzyme Sulfotransferase 1A1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth SuppressionDeborah M Rothman, Xiaolin Gao, Elizabeth George, et al.
Plos One|September 18, 2015
Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor LineagesAnupama Reddy, Joseph D Growney, Nick S Wilson, et al.
Cancer Discovery|August 10, 2012
Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growthFred Harbinski, Vanessa J Craig, Sneha Sanghavi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersGregory R Hoffman, Rami Rahal, Frank Buxton, et al.
Plos One|July 21, 2012
R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5Heinz Ruffner, Joëlle Sprunger, Olga Charlat, et al.
Nature Communications|June 24, 2021
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicinesLiyang Zhang, John A Zuris, Ramya Viswanathan, et al.
Nature Medicine|February 10, 2025
A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levelsFrederic Tremblay, Qiang Xiong, Shrijal S Shah, et al.
Nature Medicine|January 22, 2019
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10Morgan L Maeder, Michael Stefanidakis, Christopher J Wilson, et al.
Pageof 5